diphenyliodonium has been researched along with arachidonic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessandri, C; Camastra, C; Iuliano, L; Praticò, D; Violi, F | 1 |
Bonnefont-Rousselot, D; Borderie, D; Chenevier-Gobeaux, C; Ekindjian, OG; Poiraudeau, S; Simonneau, C; Therond, P | 1 |
2 other study(ies) available for diphenyliodonium and arachidonic acid
Article | Year |
---|---|
Polymorphonuclear leukocyte-derived O2-reactive species activate primed platelets in human whole blood.
Topics: Arachidonic Acid; Biphenyl Compounds; Collagen; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Onium Compounds; Platelet Activation; Platelet Aggregation; Thromboxane A2 | 1993 |
Implication of cytosolic phospholipase A2 (cPLA2) in the regulation of human synoviocyte NADPH oxidase (Nox2) activity.
Topics: Acetophenones; Anti-Infective Agents; Arachidonic Acid; Arthritis, Rheumatoid; Biphenyl Compounds; Cells, Cultured; Cytosol; Enzyme Induction; Enzyme Inhibitors; Humans; Interleukin-1beta; Ion Channels; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Onium Compounds; Osteoarthritis; Phospholipases A; Phospholipases A2; Superoxides; Synovial Membrane; Tumor Necrosis Factor-alpha | 2007 |